Evaluation of influenza vaccine-immunogenicity in cell-mediated immunity

Cell Immunol. 2016 Dec:310:165-169. doi: 10.1016/j.cellimm.2016.09.005. Epub 2016 Sep 7.

Abstract

The immunological effect of influenza vaccines cannot be evaluated accurately using an antibody titer. Therefore, we used a new method that measures cell-mediated immunity to investigate changes in the amount of interferon-gamma (IFN-γ) produced after vaccination in response to the vaccine antigen. The study was conducted during the 2014-2015 influenza season in 23 adults, using a vaccine that contained three types of antigen. The IFN-γ level increased by at least 1.5 times in 65% (15/23) of cases in response to the H1N1 antigen, in 57% (13/23) of cases in response to the H3N2 antigen, and in 57% (13/23) of cases in response to the B antigen. During the study period, 4 subjects developed type A influenza. Our data showed that the IFN-γ level did not increase by 1.5 times in these subjects. We propose that the efficacy of influenza vaccines may be evaluated by measuring changes in the level of IFN-γ produced in response to influenza vaccine.

Keywords: Antigen; Cell-mediated immunity; Humoral immunity; Influenza; Interferon-gamma; Vaccine.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antigens, Viral / immunology
  • Cells, Cultured
  • Female
  • Humans
  • Immunity, Cellular
  • Influenza A Virus, H1N1 Subtype / immunology*
  • Influenza A Virus, H3N2 Subtype / immunology*
  • Influenza Vaccines / immunology*
  • Influenza, Human / immunology*
  • Influenza, Human / prevention & control
  • Interferon-gamma / metabolism
  • Leukocytes, Mononuclear / immunology*
  • Lymphocyte Activation
  • Male
  • Middle Aged

Substances

  • Antigens, Viral
  • Influenza Vaccines
  • Interferon-gamma